Abstract
Traumatic brain injury (TBI) causes brain damage, which involves primary and secondary injury mechanisms. Primary injury causes local brain damage, while secondary damage begins with inflammatory activity followed by disruption of the blood–brain barrier (BBB), peripheral blood cells infiltration, brain edema, and the discharge of numerous immune mediators including chemotactic factors and interleukins. TBI alters molecular signaling, cell structures, and functions. Besides tissue damage such as axonal damage, contusions, and hemorrhage, TBI in general interrupts brain physiology including cognition, decision-making, memory, attention, and speech capability. Regardless of the deep understanding of the pathophysiology of TBI, the underlying mechanisms still need to be assessed with a desired therapeutic agent to control the consequences of TBI. The current review gives a brief outline of the pathophysiological mechanism of TBI and various biochemical pathways involved in brain injury, pharmacological treatment approaches, and novel targets for therapy.
Similar content being viewed by others
References
Aarts MM, Tymianski M (2005) TRPMs and neuronal cell death. Pflügers Archiv 45:243–249. https://doi.org/10.1007/s00424-005-1439-x
Abe N, Borson SH, Gambello MJ, Wang F, Cavalli V (2010) Mammalian target of rapamycin (mTOR) activation increases axonal growth capacity of injured peripheral nerves. J Biol Chem 285:28034–28043. https://doi.org/10.1074/jbc.M110.125336
Aktories K and Just I eds (2004) Special Issue on Emerging Bacterial Toxins. https://www.springer.com/gp/book/9783540231318
Andriessen TM, Jacobs B, Vos PE (2010) Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury. J Cell Mol Med 14:2381–2392. https://doi.org/10.1111/j.1582-4934.2010.01164.x
Ansari MA, Roberts KN, Scheff SW (2008) Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury. Free Radic Biol Med 45:443–452. https://doi.org/10.1016/j.freeradbiomed.2008.04.038
Arien-Zakay H, Gincberg G, Nagler A, Cohen G, Liraz-Zaltsman S, Trembovler V, Alexandrovich AG, Matok I, Galski H, Elchalal U, Lelkes PI (2014) Neurotherapeutic effect of cord blood derived CD45+ hematopoietic cells in mice after traumatic brain injury. J Neurotrauma 31:1405–1416. https://doi.org/10.1089/neu.2013.3270
Bains M, Hall ED (2012) Antioxidant therapies in traumatic brain and spinal cord injury. Biochim Biophys Acta 1822:675–684. https://doi.org/10.1016/j.bbadis.2011.10.017
Bhowmick S, D’Mello V, Caruso D, Abdul-Muneer PM (2019) Traumatic brain injury-induced downregulation of Nrf2 activates inflammatory response and apoptotic cell death J Mol Med 97: 1627–1641. https://doi.org/10.1007/s00109-019-01851-4
Blaya MO, Tsoulfas P, Bramlett HM, Dietrich WD (2015) Neural progenitor cell transplantation promotes neuroprotection, enhances hippocampal neurogenesis, and improves cognitive outcomes after traumatic brain injury. Exp Neurol 264:67–81. https://doi.org/10.1016/j.expneurol.2014.11.014
Brustovetsky T, Bolshakov A, Brustovetsky N (2010) Calpain activation and Na+/Ca2+ exchanger degradation occur downstream of calcium deregulation in hippocampal neurons exposed to excitotoxic glutamate. J Neurosci Res 88:1317–1328. https://doi.org/10.1002/jnr.22295
Bye N, Habgood MD, Callaway JK, Malakooti N, Potter A, Kossmann T, Morganti-Kossmann MC (2007) Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp Neurol 204:220–233. https://doi.org/10.1016/j.expneurol.2006.10.013
Cao Q, Benton RL, Whittemore SR (2002) Stem cell repair of central nervous system injury. J Neurosci Res 68:501–510. https://doi.org/10.1002/jnr.10240
Carbonell WS, Mandell JW (2003) Transient neuronal but persistent astroglial activation of ERK/MAP kinase after focal brain injury in mice. J Neurotrauma 20: 327–336 101089/089771503765172282. https://doi.org/10.1089/089771503765172282
Carmody RJ, Chen YH (2007) Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. Cell Mol Immunol 4: 31–41. https://pubmed.ncbi.nlm.nih.gov/17349209/
Casas-Tinto S, Zhang Y, Sanchez-Garcia J, Gomez-Velazquez M, Rincon-Limas DE, Fernandez-Funez P (2011) The ER stress factor XBP1s prevents amyloid-β neurotoxicity. Hum Mol Gen 20:2144–2160. https://doi.org/10.1093/hmg/ddr100
Chamoun R, Suki D, Gopinath SP, Goodman JC, Robertson C (2010) Role of extracellular glutamate measured by cerebral microdialysis in severe traumatic brain injury. J Neurosurg 113:564–570. https://doi.org/10.3171/2009.12.jns09689
Chang CZ, Wu SC, Lin CL, Kwan AL (2015) Curcumin, encapsulated in nano-sized PLGA, down-regulates nuclear factor κB (p65) and subarachnoid hemorrhage induced early brain injury in a rat model. Brain Res 1608:215–224. https://doi.org/10.1016/j.brainres.2015.02.039
Chen X, Liu Z, Cao BB, Qiu YH, Peng YP (2017) TGF-β1 neuroprotection via inhibition of microglial activation in a rat model of Parkinson’s disease. J Neuroimmune Pharmacol 12:433–446. https://doi.org/10.1007/s11481-017-9732-y
Chi X, Wang S, Huang Y, Stamnes M, Chen JL (2013) Roles of rho GTPases in intracellular transport and cellular transformation. Int J Mol Sci 14: 7089–7108. https://doi.org/10.3390/ijms14047089
Cutler SM, Cekic M, Miller DM, Wali B, VanLandingham JW, Stein DG (2007) Progesterone improves acute recovery after traumatic brain injury in the aged rat. J Neurotrauma 24:1475–1486. https://doi.org/10.1089/neu.2007.0294
Dash PK, Johnson D, Clark J, Orsi SA, Zhang M, Zhao J, Grill RJ, Moore AN, Pati S (2011) Involvement of the glycogen synthase kinase-3 signaling pathway in TBI pathology and neurocognitive outcome. PloS One 6: pe24648. https://doi.org/10.1371/journal.pone.0024648
Deng Y, Thompson BM, Gao X, Hall ED (2007) Temporal relationship of peroxynitrite-induced oxidative damage, calpain-mediated cytoskeletal degradation and neurodegeneration after traumatic brain injury. Exp Neurol 205:154–165. https://doi.org/10.1016/j.expneurol.2007.01.023
Dibble CC, Cantley LC (2015) Regulation of mTORC1 by PI3K signaling Trends. Cell Biol 25:545–555. https://doi.org/10.1016/j.tcb.2015.06.002
Dietrich WD, Bramlett HM (2016) Therapeutic hypothermia and targeted temperature management in traumatic brain injury: Clinical challenges for successful translation. Brain Res 1640:94–103. https://doi.org/10.1016/j.brainres.2015.12.034
Duberley KE, Heales SJR, Abramov AY, Chalasani A, Land JM, Rahman S, Hargreaves IP (2014) Effect of Coenzyme Q10 supplementation on mitochondrial electron transport chain activity and mitochondrial oxidative stress in Coenzyme Q10 deficient human neuronal cells Int. J Biochem Cell Biol 50:60–63. https://doi.org/10.1016/j.tcb.2015.06.002
Dubreuil CI, Marklund N, Deschamps K, McIntosh TK, McKerracher L (2006) Activation of Rho after traumatic brain injury and seizure in rats. Exp Neurol 198:361–369. https://doi.org/10.1016/j.expneurol.2005.12.002
Ehninger D, Kempermann G (2008) Neurogenesis in the adult hippocampus. Cell Tissue Res 331:243–250. https://doi.org/10.1007/s00441-007-0478-3
Erlich S, Alexandrovich A, Shohami E, Pinkas-Kramarski R (2007) Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis 26: 86–93. https://doi.org/10.1016/j.nbd.2006.12.003
Fang X, Yu SX, Lu Y, Bast RC, Woodgett JR, Mills GB (2000) Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase. PNAS 97:11960–11965. https://doi.org/10.1073/pnas.220413597
Farr SA, Niehoff ML, Kumar VB, Roby DA, Morley JE (2019) Inhibition of Glycogen Synthase Kinase 3β as a Treatment for the Prevention of Cognitive Deficits after a Traumatic Brain Injury. J Neurotrauma 36:869–875. https://doi.org/10.1089/neu.2018.5999
Foks KA, Cnossen MC, Dippel DW, Maas AI, Menon D, van der Naalt J, Steyerberg EW, Lingsma HF, Polinder S (2017) Management of mild traumatic brain injury at the emergency department and hospital admission in Europe: a survey of 71 neurotrauma centers participating in the CENTER-TBI study. J Neurotrauma 34:2529–2535. https://doi.org/10.1089/neu.2016.4919
Folkerts MM, Parks EA, Dedman JR, Kaetzel MA, Lyeth BG, Berman RF (2007) Phosphorylation of calcium calmodulin-dependent protein kinase II following lateral fluid percussion brain injury in rats. J Neurotrauma 24:638–650. https://doi.org/10.1089/neu.2006.0188
Follett PL, Rosenberg PA, Volpe JJ, Jensen FE (2000) NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 20:9235–9241. https://doi.org/10.1523/JNEUROSCI.20-24-09235.2000
Forde JA, Dale TC (2007) Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol Life Sci 64:1930–1944. https://doi.org/10.1007/s00018-007-7045-7
Forgione N, Fehlings MG (2014) Rho-ROCK inhibition in the treatment of spinal cord injury World. Neurosurg 82:e535–e539. https://doi.org/10.1016/j.wneu.2013.01.009
Forraz N, Wright KE, Jurga M, McGuckin CP (2013) Experimental therapies for repair of the central nervous system: stem cells and tissue engineering. J Tissue Eng Regen M 7:523–536. https://doi.org/10.1002/term.552
Frugier T, Morganti-Kossmann MC, O’Reilly D, Mclean CA (2010) in situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J Neurotrauma 27:497–507. https://doi.org/10.1089/neu.2009.1120
Fünfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM, Tzvetanova ID, Möbius W, Diaz F (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485:517–521. https://doi.org/10.1038/nature11007
Gennai S, Monsel A, Hao Q, Liu J, Gudapati V, Barbier EL, Lee JW (2015) Cell-based therapy for traumatic brain injury. Br J Anaesth 115:203–212. https://doi.org/10.1093/bja/aev229
Ghosh S, Garg S, Ghosh S (2020) Cell-Derived Exosome Therapy: a novel approach to treat post-traumatic brain Iinjury mediated neural injury. ACS Chem Neurosci 11:2045–2047. https://doi.org/10.1021/acschemneuro.0c00368
Gincberg G, Shohami E, Lazarovici P, Elchalal U (2018) Human umbilical cord blood CD45+ pan-hematopoietic cells induced a neurotherapeutic effect in mice with traumatic brain injury: Immunophenotyping, comparison of maternal and neonatal parameters, and immunomodulation. J Mol Neurosci 64:185–199. https://doi.org/10.1007/s12031-017-1008-8
Goodman JC, Van M, Gopinath SP, Robertson CS (2009) Pro-inflammatory and pro-apoptotic elements of the neuroinflammatory response are activated in traumatic brain injury. Acta Neurochir Suppl 102: 437–439. https://doi.org/10.1007/978-3-211-85578-285
Grewal AK, Singh N, Singh TG (2019) Neuroprotective effect of pharmacological postconditioning on cerebral ischaemia–reperfusion-induced injury in mice. J Pharm Pharmacol 71:956–970. https://doi.org/10.1111/jphp.13073
Gritti A, Vescovi AL, Galli R (2002) Adult neural stem cells: plasticity and developmental potential. J Physiol Paris 96:81–90. https://doi.org/10.1016/S0928-4257(01)00083-3
Guo D, Zeng L, Brody DL, Wong M (2013) Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury PloS One 8(5):e64078. https://doi.org/10.1371/journal.pone.0064078
Hasegawa Y, Suzuki H, Sozen T, Altay O, Zhang JH (2011) Apoptotic mechanisms for neuronal cells in early brain injury after subarachnoid hemorrhage In Early Brain Injury or Cerebral Vasospasm, 43–48. https://doi.org/10.1007/978-3-7091-0353-18
Hassan H, Grecksch G, Rüthrich H, Krug M (1999) Effects of nicardipine, an antagonist of L-type voltage-dependent calcium channels, on kindling development, kindling-induced learning deficits and hippocampal potentiation phenomena. Neuropharmacol 38:1841–1850. https://doi.org/10.1016/S0028-3908(99)00067-2
He H, Liu W, Zhou Y, Liu Y, Weng P, Li Y, Fu H (2018) Sevoflurane post-conditioning attenuates traumatic brain injury-induced neuronal apoptosis by promoting autophagy via the PI3K/AKT signaling pathway. Drug Des Devel Ther 12 https://doi.org/10.2147/dddt.s158313
Hellewell SC, Yan EB, Agyapomaa DA, Bye N, Morganti-Kossmann MC (2010) Post-traumatic hypoxia exacerbates brain tissue damage: analysis of axonal injury and glial responses. J Neurotrauma 27:1997–2010. https://doi.org/10.1089/neu.2009.1245
Homsi S, Federico F, Croci N, Palmier B, Plotkine M, Marchand-Leroux C, Jafarian-Tehrani M (2009) Minocycline effects on cerebral edema: relations with inflammatory and oxidative stress markers following traumatic brain injury in mice. Brain Res 1291:122–132. https://doi.org/10.1016/j.brainres.2009.07.031
Hyder AA, Wunderlich CA, Puvanachandra P, Gururaj G, Kobusingye OC (2007) The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation 22:341–353. https://doi.org/10.3233/NRE-2007-22502
Hu J, Chen L, Huang X, Wu K, Ding S, Wang W, Wang B, Smith C, Ren C, Ni H, ZhuGe Q (2019) Calpain inhibitor MDL28170 improves the transplantation-mediated therapeutic effect of bone marrow-derived mesenchymal stem cells following traumatic brain injury. Stem Cell Res Ther 10:1–13. https://doi.org/10.1186/s13287-019-1210-4
Inoue R (2005) TRP channels as a newly emerging non-voltage-gated CA2+ entry channel superfamily. Curr Pharm Des 11:1899–1914. https://doi.org/10.2174/1381612054021079
Islam A, Choudhury ME, Kigami Y, Utsunomiya R, Matsumoto S, Watanabe H, Kumon Y, Kunieda T, Yano H, Tanaka J (2018) Sustained anti-inflammatory effects of TGF-β1 on microglia/macrophages. Biochim Biophys Acta Mol Basis 1864:721–734. https://doi.org/10.1016/j.bbadis.2017.12.022
Ismael S, Zhao L, Nasoohip S, Ishrat T (2018) Inhibition of the NLRP3-inflammasome s a potential approach for neuroprotection after stroke. Sci Rep 8: 1–9. https://www.nature.com/articles/s41598-018-24350-x
Ji X, Tian Y, Xie K, Liu W, Qu Y, Fei Z (2012) Protective effects of hydrogen-rich saline in a rat model of traumatic brain injury via reducing oxidative stress. J Surg Res 178:9–16. https://doi.org/10.1016/j.jss.2011.12.038
Jiang L, Xia QJ, Dong XJ, Hu Y, Chen ZW, Chen K, Wang KH, Liu J, Wang TH (2017) Neuroprotective effect of breviscapine on traumatic brain injury in rats associated with the inhibition of GSK3β signaling pathway. Brain Res 1660:1–9. https://doi.org/10.1016/j.brainres.2017.01.031
Johnson VE, Stewart JE, Begbie FD, Trojanowski JQ, Smith DH, Stewart W (2013) Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain 136:28–42. https://doi.org/10.1093/brain/aws322
Khajavikhan J, Vasigh A, Khani A, Jaafarpour M, Kokhazade T (2016) Outcome and predicting factor following severe traumatic brain injury: a retrospective cross-sectional study. JCDR 10 https://doi.org/10.7860/JCDR/2016/16390.7294
Kilbaugh TJ, Bhandare S, Lorom DH, Saraswati M, Robertson CL, Margulies SS (2011) Cyclosporin A preserves mitochondrial function after traumatic brain injury in the immature rat and piglet. J Neurotraum 28:763–774. https://doi.org/10.1089/neu.2010.1635
Kim HS, Suh YH (2009) Minocycline and neurodegenerative diseases. Behav Brain Res 196:168–179. https://doi.org/10.1016/j.bbr.2008.09.040
Kleindienst A, Harvey HB, Rice AC, Müller C, Hamm RJ, Gaab MR, Bullock MR (2004) Intraventricular infusion of the neurotrophic protein S100B improves cognitive recovery after fluid percussion injury in the rat. J Neurotrauma 21:541–547. https://doi.org/10.1089/089771504774129874
Kong L, Yao Y, Xia Y, Liang X, Ni Y, Yang J (2019) Osthole alleviates inflammation by down-regulating NF-κB signaling pathway in traumatic brain injury. Immunopharmacol Immuntoxicol 41:349–360. https://doi.org/10.1080/08923973.2019.1608560
Kovesdi E, Kamnaksh A, Wingo D, Ahmed F, Grunberg NE, Long JB, Kasper CE, Agoston DV (2012) Acute minocycline treatment mitigates the symptoms of mild blast-induced traumatic brain injury. Front Neurol. https://doi.org/10.3389/fneur.2012.00111
Kraft AD, Johnson DA, Johnson JA (2004) Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci 25:1101–1112. https://doi.org/10.1523/jneurosci.3817-03.2004
Kubo T, Hata K, Yamaguchi A, Yamashita T (2007) Rho-ROCK inhibitors as emerging strategies to promote nerve regeneration. Curr Pharm Des 13:2493–2499. https://doi.org/10.2174/138161207781368657
Kumar V, Zhang MX, Swank MW, Kunz J, Wu GY (2005) Regulation of dendritic morphogenesis by Ras–PI3K–Akt–mTOR and Ras–MAPK signaling pathways. J Neurosci 25:11288–11299. https://doi.org/10.1523/jneurosci.2284-05.2005
Lamkanfi M, Walle LV, Kanneganti TD (2011) Deregulated inflammasome signaling in disease. Immunol Rev 243:163–173. https://doi.org/10.1111/j.1600-065x.2011.01042.x
LaPlaca MC, Thibault LE (1998) Dynamic mechanical deformation of neurons triggers an acute calcium response and cell injury involving the N-methyl-D-aspartate glutamate receptor. J Neurosci Res 52:220–229. https://doi.org/10.1002/(sici)1097-4547(19980415)52:2%3C220::aid-jnr10%3E3.0.co;2-b
Lee AYW, Ng SY (2019) Traumatic brain injuries: pathophysiology and potential therapeutic targets. Front Cell Neurosci 13 https://doi.org/10.3389/fncel.2019.00528
Li DW, Liu ZQ, Chen W, Yao M, Li GR (2014) Association of glycogen synthase kinase-3β with Parkinson’s disease. Mol Med Rep 9:2043–2050. https://doi.org/10.3892/mmr.2014.2080
Liliental J, Chang DD (1998) Rack1, a receptor for activated protein kinase C, interacts with integrin β subunit. J Biol Chem 273:2379–2383. https://doi.org/10.1074/jbc.273.4.2379
Liu T, Zhang L, Joo D, Sun SC (2017) NF-κB signaling in inflammation. Signal Transduct Target Ther 2:1–9. https://doi.org/10.1038/sigtrans.2017.23
Llorens-Marítin MJ, Hernández J, F and Ávila J, (2014) GSK-3β, a pivotal kinase in Alzheimer disease. Front Mol Neurosci 7:p46. https://doi.org/10.3389/fnmol.2014.00046
Lord-Fontaine S, Yang F, Diep Q, Dergham P, Munzer S, Tremblay P, McKerracher L (2008) Local inhibition of Rho signaling by cell-permeable recombinant protein BA-210 prevents secondary damage and promotes functional recovery following acute spinal cord injury. J Neurotrauma 25:1309–1322. https://doi.org/10.1089/neu.2008.0613
Lotocki G, de Rivero Vaccari JP, Perez ER, Sanchez-Molano J, Furones-Alonso OB, H M, and Dietrich WD, (2009) Alterations in blood-brain barrier permeability to large and small molecules and leukocyte accumulation after traumatic brain injury: effects of post-traumatic hypothermia. J Neurotrauma 26:1123–1134. https://doi.org/10.1089/neu.2008.0802
Lu D, Goussev A, Chen J, Pannu P, Li Y, Mahmood A, Chopp M (2004) Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury. J Neurotrauma 21:21–32. https://doi.org/10.1089/089771504772695913
Ma J, Wu R, Zhang Q, Wu JB, Lou J, Zheng Z, Ding JQ, Yuan Z (2014) DJ-1 interacts with RACK1 and protects neurons from oxidative-stress-induced apoptosis. Biochem J 462:489–497. https://doi.org/10.1042/bj20140235
Maas AI (2017) Traumatic brain injury in India: A big problem in need of data. Neurol India 65:257–258. https://doi.org/10.4103/0028-3886.201848
Maas AI, Stocchetti N, Bullock R (2008) Moderate and severe traumatic brain injury in adults. Lancet Neurol 7:728–741. https://doi.org/10.1016/s1474-4422(08)70164-9
Mattson MP, Camandola S (2001) NF-κB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 107:247–254. https://doi.org/10.1172/jci11916
Maxwell WL (2012) Traumatic brain injury in the neonate, child and adolescent human: an overview of pathology. Int J Dev Neurosci 30:167–183. https://doi.org/10.1016/j.ijdevneu.2011.12.008
Mbye LH, Singh IN, Sullivan PG, Springer JE, Hall ED (2008) Attenuation of acute mitochondrial dysfunction after traumatic brain injury in mice by NIM811, a non-immunosuppressive cyclosporin. Analog Exp Neurol 2009:243–253. https://doi.org/10.1016/j.expneurol.2007.09.025
McKeating EG, Andrews PJ (1998) Cytokines and adhesion molecules in acute brain injury. Br J Anaesth 80:77–84
Meldrum BS (2000) Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 130:1007–1015. https://doi.org/10.1093/jn/130.4.1007s
Molcanyi M, Riess P, Bentz K, Maegele M, Hescheler J, Schäfke B, Trapp T, Neugebauer E, Klug N, Schäfer U (2007) Trauma-associated inflammatory response impairs embryonic stem cell survival and integration after implantation into injured rat brain. J Neurotrauma 24:625–637. https://doi.org/10.1089/neu.2006.0180
Mortezaee K, Khanlarkhani N, Beyer C, Zendedel A (2018) Inflammasome: its role in traumatic brain and spinal cord injury. J Cell Physiol 233:5160–5169. https://doi.org/10.1002/jcp.26287
Mulherkar S, Tolias KF (2020) RhoA-ROCK signaling as a therapeutic target in traumatic brain injury. Cells 9:245. https://doi.org/10.3390/cells9010245
Naga KK, Sullivan PG, Geddes JW (2007) High cyclophilin D content of synaptic mitochondria results in increased vulnerability to permeability transition. J Neurosci 27:7469–7475. https://doi.org/10.1523/JNEUROSCI.0646-07.2007
Ni H, Rui Q, Xu Y, Zhu J, Gao F, Dang B, Li D, Gao R, Chen G (2018) RACK1 upregulation induces neuroprotection by activating the IRE1-XBP1 signaling pathway following traumatic brain injury in rats. Exp Neurol 304:102–113. https://doi.org/10.1016/j.expneurol.2018.03.003
Nickels JL, Schneider WN, Dombovy ML, Wong TM (1999) Clinical use of amantadine in brain injury rehabilitation. Brain Inj 8:709–718. https://doi.org/10.3109/02699059409151025
Nikolaeva I, Crowell B, Valenziano J, Meaney D, D’Arcangelo G (2016) Beneficial effects of early mTORC1 inhibition after traumatic brain injury. J Neurotrauma 33:183–193. https://doi.org/10.3109/02699059409151025
Oliva AA, Kang Y, Sanchez-Molano J, Furones C, Atkins CM (2012) STAT3 signaling after traumatic brain injury. J Neurochem 120:710–720. https://doi.org/10.1111/j.1471-4159.2011.07610.x
Otani N, Nawashiro H, Fukui S, Nomura N, Yano A, Miyazawa T, Shima K (2002) Differential activation of mitogen-activated protein kinase pathways after traumatic brain injury in the rat hippocampus . J Cerebr Blood F Met 22: 327–334. https://doi.org/10.1097/00004647-200203000-00010
Pandya JD, Readnower RD, Patel SP, Yonutas HM, Pauly JR, Goldstein GA, Rabchevsky AG, Sullivan PG (2014) N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI. Exper Neurol 257:106–113. https://doi.org/10.1016/j.expneurol.2014.04.020
Panikashvili D, Mechoulam R, Beni SM, Alexandrovich A, Shohami E (2005) CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition. J Cereb Blood Flow Metabol 25:477–484. https://doi.org/10.1038/sj.jcbfm.9600047
Patel KS (2016) Post-TBI Hippocampal Neurogenesis in Different TBI Models. https://doi.org/10.25772/8T45-WB49
Peeters W, Majdan M, Brazinova A, Nieboer D, Maas AI (2017) Changing epidemiological patterns in traumatic brain injury: a longitudinal hospital-based study in Belgium. Neuroepidemiol 48:63–70. https://doi.org/10.1159/000471877
Peeters W, van den Brande R, Polinder S, Brazinova I (2015) Epidemiology of traumatic brain injury in Europe. Acta Neurochir 157: 1683–1696. https://pubmed.ncbi.nlm.nih.gov/?term=Brazinova+A&cauthor_id=26269030
Pennypacker KR, Kassed CA, Eidizadeh S, Saporta S, Sanberg PR, Willing AE (2001) NF-κB p50 is increased in neurons surviving hippocampal injury. Exp Neurol 172:307–319. https://doi.org/10.1006/exnr.2001.7817
Plata-Salaman CR (2002) Brain cytokines and disease. Acta Neurochir 14:262–278. https://doi.org/10.1034/j.1601-5215.2002.140602.x
Raghupathi R, Graham DI, Mcintosh TK (2000) Apoptosis after traumatic brain injury. J Neurotrauma 17:927–938. https://doi.org/10.1089/neu.2000.17.927
Rao M (2007) Tumorigenesis and embryonic stem cell-derived therapy. Stem Cells Dev 16:903–904. https://doi.org/10.1089/scd.2007.9986
Rossi D, Gaidano G (2003) Messengers of cell death: apoptotic signaling in health and disease. Haematologica 88:212–218. https://doi.org/10.3324/%25x
Sadowski K, Kotulska-Jóźwiak K, Jóźwiak S (2015) Role of mTOR inhibitors in epilepsy treatment. Pharmacol Rep 67:636–646. https://doi.org/10.1016/j.pharep.2014.12.017
Safinia C, Bershad EM, Clark HB, SantaCruz K, Alakbarova N, Suarez JI, Divani AA (2016) Chronic traumatic encephalopathy in athletes involved with high-impact sports. J Vasc Interv Neurol 9:34–48
Samii A, Badie H, Fu K, Luther RR, HovdA DA (1999) Effects of an N-type calcium channel antagonist (SNX 111; Ziconotide) on calcium-45 accumulation following fluid-percussion injury. J Neurotrauma 16:879–892. https://doi.org/10.1089/neu.1999.16.879
Sanz O, Acarin L, González B, Castellano B (2002) NF-κB and IκBα expression following traumatic brain injury to the immature rat brain. J Neurosci Res 67:772–780. https://doi.org/10.1002/jnr.10140
Schmitz I, Kirchhoff S, Krammer PH (2000) Regulation of death receptor-mediated apoptosis pathways. Int J Biochem Cell Biol 32:1123–1136. https://doi.org/10.1016/s1357-2725(00)00048-0
Semple BD, Bye N, Rancan M, Ziebell JM, Morganti-Kossmann MC (2010) Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2−/− mice. J Cereb Blood Flow Metab 30, 769–782. https://doi.org/10.1038/2Fjcbfm.2009.262
Shapira M, Licht A, Milman A, Pick CG, Shohami E, Eldar-Finkelman H (2007) Role of glycogen synthase kinase-3β in early depressive behavior induced by mild traumatic brain injury. Mol Cell. Neurosci 34: 571–577.https://doi.org/10.1016/j.mcn.2006.12.006
Shen M, Wang S, Wen X, Han XR, Wang YJ, Zhou XM, Zhang MH, Wu DM, Lu J, Zheng YL (2017) Dexmedetomidine exerts neuroprotective effect via the activation of the PI3K/Akt/mTOR signaling pathway in rats with traumatic brain injury. Biomed Pharmacother 95:885–893. https://doi.org/10.1016/j.biopha.2017.08.125
Shih AY, Li P, Murphy TH (2005) A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J Neurosci 25:10321–10335. https://doi.org/10.1523/JNEUROSCI.4014-05.2005
Shim HY, Park JH, Paik HD, Nah SY, Kim DS, Han YS (2007) Genistein-induced apoptosis of human breast cancer MCF-7 cells involves calpain–caspase and apoptosis signaling kinase 1–p38 mitogen-activated protein kinase activation cascades. Anticancer drugs 18:649–657. https://doi.org/10.1097/cad.0b013e3280825573
Shohami E, Kohen R (2011) The role of reactive oxygen species in the pathogenesis of traumatic brain injury in Oxidative Stress and Free Radical Damage in Neurology eds N Gadoth, and HH Göbel (Humana Press), 99–118
Shohami E, Mechoulam R (2000) Dexanabinol (HU-211): A nonpsychotropic cannabinoid with neuroprotective properties. Drug Develop Res 50:211–215. https://doi.org/10.1002/1098-2299(200007/08)50:3/4%3C211::AID-DDR3%3E3.0.CO;2-G
Shohami E, Beit-Yannai E, Horowitz M, Kohen R (1997) Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome.J Cereb Blood Flow Metab 17: 1007–1019. https://doi.org/10.1007/978-1-60327-514-97
Singh IN, Sullivan PG, Deng Y, Mbye LH, Hall ED (2006) Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy. J Cereb Blood Flow Metab 26: 1407–1418. https://doi.org/10.1038/2Fsj.jcbfm.9600297
Singh P, Doshi S, Spaethling JM, Hockenberry AJ, Patel TP, Geddes -Klein, DM, Lynch, DR & Meaney DF, (2012) N -methyl - D -aspartate receptor mechanosensitivity is governed by C terminus of NR2B subunit. J Biol Chem 287:4348–4359. https://doi.org/10.1074/jbc.M111.253740
Singh S, Singh TG (2020) Role of Nuclear factor kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach. Curr Neuropharmacol. https://doi.org/10.2174/1570159X18666200207120949
Smith DH, Chen XH, Pierce JE, Wolf JA, Trojanowski JQ, Graham DI, Mcintosh TK (1997) Progressive atrophy and neuron death for one year following brain trauma in the rat. J Neurotrauma 14:715–727. https://doi.org/10.1089/neu.1997.14.715
Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J Contr Release 70:1–20. https://doi.org/10.1016/S0168-3659(00)00339-4
Stein DG (2015) Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials. Brain Inj 29:1259–1272. https://doi.org/10.3109/02699052.2015.1065344
Stocchetti N, Carbonara M, Citerio G, Ercole A, Skrifvars MB, Smielewski P, Zoerle T, Menon DK (2017) Severe traumatic brain injury: targeted management in the intensive care unit. Lancet Neurol 16:452–464. https://doi.org/10.1016/S1474-4422(17)30118-7
Strniskova M, Barancik M, Ravingerova T (2002) Mitogen-activated protein kinases and their role in regulation of cellular processes. Gen Physiol Biophys 21:231–256
Su E, Bell M (2016) Diffuse axonal injury. Transl Res Traumatic brain Inj research in traumatic brain injury 57:1–41
Sullivan PG, Bruce-Keller AJ, Rabchevsky AG, Christakos S, Clair DKS, Mattson MP, Scheff SW (1999a) Exacerbation of damage and altered NF-κB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J Neurosci 19:6248–6256. https://doi.org/10.1523/JNEUROSCI.19-15-06248.1999
Sullivan PG, Thompson MB, Scheff SW (1999b) Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp Neurol 160:226–234. https://doi.org/10.1006/exnr.1999.7197
Sun D, Bullock MR, McGinn MJ, Zhou Z, Altememi N, Hagood S, Hamm R, Colello RJ (2009) Basic fibroblast growth factor-enhanced neurogenesis contributes to cognitive recovery in rats following traumatic brain injury. Exp Neurol 216:56–65. https://doi.org/10.1016/j.expneurol.2008.11.011
Susin SA, Zamzami N, Kroemer G (1998) Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta 1366:151–165. https://doi.org/10.1016/S0005-2728(98)00110-8
Suzuki T, Yamamoto M (2017) Stress-sensing mechanisms and the physiological roles of the Keap1–Nrf2 system during cellular stress. J Biol Chem 292:16817–16824. https://doi.org/10.1074/jbc.R117.800169
Taguchi A, Sakai C, Soma T, Kasahara Y, Stern DM, Kajimoto K, Ihara M, Daimon T, Yamahara K, Doi K, Kohara N (2015) Intravenous autologous bone marrow mononuclear cell transplantation for stroke: phase1/2a clinical trial in a homogeneous group of stroke patients Stem. Cells Dev 24: 2207–2218
Talsky A, Pacione LR, Shaw T, Wasserman L, Lenny A, Verma A, Hurwitz G, Waxman R, Morgan A, Bhalerao S (2010) Pharmacological interventions for traumatic brain injury. BCMJ 53:26–31. https://doi.org/10.1089/scd.2015.0160
Tan L, Ge H, Tang J, Fu C, Duanmu W, Chen Y, Hu R, Sui J, Liu X, Feng H (2015) Amantadine preserves dopamine level and attenuate depression-like behavior induced by traumatic brain injury in rats. Behav Brain Res 279:274–282. https://doi.org/10.1016/j.bbr.2014.10.037
Tan Y, Dourdin N, Wu C, De Veyra T, Elce JS, Greer PA (2006) Ubiquitous calpains promote caspase-12 and JNK activation during endoplasmic reticulum stress-induced apoptosis. J Biol Chem 281:16016–16024. https://doi.org/10.1074/jbc.M601299200
Tao L, Li D, Liu H, Jiang F, Xu Y, Cao Y, Gao R, Chen G (2018) Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-κB and MAPK signaling pathway. Brain Res Bull 140:154–161. https://doi.org/10.1016/j.brainresbull.2018.04.008
Taylor RA, Chang CF, Goods BA, Hammond MD, Mac Grory B, Ai Y, Steinschneider AF, Renfroe SC, AskenaseMH McCullough, LD and Kasner SE, (2017) TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage. J Clin Invest 127:280–292. https://doi.org/10.1172/JCI88647
Thompson SN, Carrico KM, Mustafa AG, Bains M, Hall ED (2010) A pharmacological analysis of the neuroprotective efficacy of the brain-and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model. J Neurotrauma 27:2233–2243. https://doi.org/10.1089/neu.2010.1474
Tsujimoto Y, Shimizu S (2007) Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 12: 835–840. https://doi.org/10.1007/s10495-006-0525-7
Valdés P, Mercado G, Vidal RL, Molina C, Parsons G, Martinez A, Galleguillos D, Schneider AD, BL and Hetz C, (2014) Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1. PNAS 111:6804–6809. https://doi.org/10.1073/pnas.1321845111
Van Gils A, Stone J, Welch K, Davidson LR, Kerslake D, Caesar D, McWhirter L, Carson A (2020) Management of mild traumatic brain injury. Prac neurol 20:213–221. https://doi.org/10.1136/practneurol-2018-002087
Vijiaratnam N, Foltynie T (2020) Therapeutic strategies to treat or prevent off episodes in adults with Parkinson’s disease. Drugs 80:775–796. https://link.springer.com/article/10.1007%2Fs40265-020-01310-2
Walker CL, Wu X, Liu NK, Xu XM (2019) Bisperoxovanadium mediates neuronal protection through inhibition of PTEN and activation of PI3K/AKT-mTOR signaling after traumatic spinal injuries. J Neurotrauma 36:2676–2687. https://doi.org/10.1089/neu.2018.6294
Wang Z, Wang YU, Wang Z, Gutkind JS, Wang Z, Wang F, Lu J, Niu G, Teng G, Chen X (2015) Engineered mesenchymal stem cells with enhanced tropism and paracrine secretion of cytokines and growth factors to treat traumatic brain injury. Stem Cells 33:456–467. https://doi.org/10.1002/stem.1878
Weber JT (2012) Altered calcium signaling following traumatic brain injury. Front Pharmacol 3:60. https://doi.org/10.3389/fphar.2012.00060
Werner C, Engelhard K (2007) Pathophysiology of traumatic brain injury. Br J Anaesth 99:4–9. https://doi.org/10.1093/bja/aem131
Wu H, Lu D, Jiang H, Xiong Y, Qu C, Li B, Mahmood A, Zhou D, Chopp M (2008a) Increase in phosphorylation of Akt and its downstream signaling targets and suppression of apoptosis by simvastatin after traumatic brain injury. J Neurosurg 109:691–698. https://doi.org/10.3171/jns/2008/109/10/0691
Wu H, Lu D, Jiang H, Xiong Y, Qu C, Li B, Mahmood A, Zhou D, Chopp M (2008b) Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. J Neurotrauma 25:130–139. https://doi.org/10.1089/neu.2007.0369
Wu X, Xu XM (2016) RhoA/Rho kinase in spinal cord injury. Neural Regen Res 11:23. https://doi.org/10.4103/1673-5374.169601
Wyllie DJA, Livesey MR, Hardingham GE (2013) Influence of GluN2 subunit identity on NMDA receptor function. Neuropharmacol 74:4–17
Xiong Y, Mahmood A, Chopp M (2010) Angiogenesis, neurogenesis and brain recovery of function following injury. Curr Opin Invest 11:p298
Xiong Y, Peterson PL, Lee CP (1999) Effect of N-acetylcysteine on mitochondrial function following traumatic brain injury in rats. J Neurotrauma 16:1067–1082. https://doi.org/10.1089/neu.1999.16.1067
Xiong Y, Zhang Y, Mahmood A, Chopp M (2015) Investigational agents for treatment of traumatic brain injury. Expert Opin Investig Drugs 24:743–760. https://doi.org/10.1517/13543784.2015.1021919
Xu HL, Liu MD, Yuan XH, Liu CX (2018a) Suppression of cortical TRPM7 protein attenuates oxidative damage after traumatic brain injury via Akt/endothelial nitric oxide synthase pathway. Neurochem Int 112:197–205. https://doi.org/10.1016/j.neuint.2017.07.010
Xu J, Fan G, Chen S, Wu Y, Xu XM, Hsu CY (1998) Methylprednisolone inhibition of TNF-α expression and NF-kB activation after spinal cord injury in rats. Mol Brain Res 59:135–142. https://doi.org/10.1016/S0169-328X(98)00142-9
Xu K, Wu F, Xu KE, Li Z, Wei X, Lu Q, Jiang T, Wu F, Xu X, Xiao J, Chen D (2018b) NaHS restores mitochondrial function and inhibits autophagy by activating the PI3K/Akt/mTOR signalling pathway to improve functional recovery after traumatic brain injury. Chem Biol Interact 286:96–105. https://doi.org/10.1016/j.cbi.2018.02.028
Xu X, Yin D, Ren H, Gao W, Li F, Sun D, Wu Y, Zhou S, Lyu L, Yang M, Xiong J (2018c) Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury. Neurol Dis 117:5–27. https://doi.org/10.1016/j.nbd.2018.05.016
Yamamoto S, Levin HS, Prough DS (2018) Mild, moderate and severe: terminology implications for clinical and experimental traumatic brain injury. Curr Opin Neurol 31:672–680. https://doi.org/10.1097/WCO.0000000000000624
Yang K, Mu XS, Hayes RL (1995) Increased cortical nuclear factor-κB (NF-κB) DNA binding activity after traumatic brain injury in rats. Neurosci Lett 197:101–104. https://doi.org/10.1016/0304-3940(95)11919-n
Yatsiv I, Grigoriadis N, Simeonidou C, Stahel PF, Schmidt OI, Alexandrovich AG, Tsenter J, Shohami E (2005) Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. J FASEB 19:1701–1703. https://doi.org/10.1096/fj.05-3907fje
Yu N, Hu S, Hao Z (2018) Beneficial effect of Stachydrine on the traumatic brain injury induced neurodegeneration by attenuating the expressions of Akt/mTOR/PI3K and TLR4/NF-κB pathway. Trans Neurosci 9:175–182. https://doi.org/10.1515/tnsci-2018-0026
Yuan D, Zhao Y, Banks WA, Bullock KM, Haney M, Batrakova E, Kabanov AV (2017) Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. Biomaterials 142:1–12. https://doi.org/10.1016/j.biomaterials.2017.07.011
Zhang D, Li H, Li T, Zhou M, Hao S, Yan H, Yu Z, Li W, Li K, Hang C (2014) TLR4 inhibitor resatorvid provides neuroprotection in experimental traumatic brain injury: implication in the treatment of human brain injury. Neurochem Int 75:11–18. https://doi.org/10.1016/j.neuint.2014.05.003
Zhang HB, Tu XK, Chen Q, Shi SS (2019) Propofol Reduces Inflammatory Brain Injury after Subarachnoid Hemorrhage: Involvement of PI3K/Akt Pathway. J Stroke Cerebrovasc Dis 28:p104375. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.104375
Zhang L, Fei M, Wang H, Zhu Y (2020) Sodium aescinate provides neuroprotection in experimental traumatic brain injury via the Nrf2-ARE pathway. Brain Res 157:26–36. https://doi.org/10.1016/j.brainresbull.2020.01.019
Zhang Y, Zhang ZG, Chopp M, Meng Y, Zhang L, Mahmood A, Xiong Y (2017) Treatment of traumatic brain injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline. J Neurosurg 126:782–795. https://doi.org/10.3171/2016.3.JNS152699
Zhao C, Zhou X, Qiu J, Xin D, Li T, Chu X, Yuan H, Wang H, Wang Z, Wang D (2019) Exosomes derived from bone marrow mesenchymal stem cells inhibit complement activation in rats with spinal cord injury. Drug Des Dev Ther 13:3693. https://doi.org/10.2147/dddt.s209636
Zhao J, Li G, Zhang Y, Su X, Hang C (2011) The potential role of JAK2/STAT3 pathway on the anti-apoptotic effect of recombinant human erythropoietin (rhEPO) after experimental traumatic brain injury of rats. Cytokine 56:343–350. https://doi.org/10.1016/j.cyto.2011.07.018
Zhao J, Moore AN, Clifton GL, Dash PK (2005) Sulforaphane enhances aquaporin‐4 expression and decreases cerebral edema following traumatic brain injury. J Neurosci Res 82:499–506. https://doi.org/10.1002/jnr.20649
Zhao J, Wang B, Wu X, Yang Z, Huang T, Guo X, Guo D, Liu Z, Song J (2020) TGFβ1 alleviates axonal injury by regulating microglia/macrophages alternative activation in traumatic brain injury. Brain Res Bull 161:21–32. https://doi.org/10.1016/j.brainresbull.2020.04.011
Zheng B, Zhang S, Ying Y, Guo X Li, H, Xu L, Ruan X (2018) Administration of Dexmedetomidine inhibited NLRP3 inflammasome and microglial cell activities in hippocampus of traumatic brain injury rats. Biosci Rep 38:BSR20180892. https://doi.org/10.1042/BSR20180892
Zhou ZW, Li F, Zheng ZT, Li YD, Chen TH, Gao WW, Chen JL, Zhang JN (2017) Erythropoietin regulates immune/inflammatory reaction and improves neurological function outcomes in traumatic brain injury. Brain Behav 7:pe00827
Acknowledgements
The authors are grateful to the Chitkara College of Pharmacy, Chitkara University, Rajpura, Patiala, Punjab, India for providing the necessary facilities to carry out the research work.
Author information
Authors and Affiliations
Contributions
Conceptualization: Conceived and designed the experiments: Thakur Gurjeet Singh. Analyzed the data: Komal Thapa, Thakur Gurjeet Singh. Wrote the manuscript: Komal Thapa and Heena Khan. Editing of the Manuscript: Heena Khan, Amarjot Kaur Grewal. Critically reviewed the article: Thakur Gurjeet Singh.
Corresponding author
Ethics declarations
Consent for Publication
All authors have read and given their consent for the final manuscript to be published.
Conflict of Interest
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Thapa, K., Khan, H., Singh, T.G. et al. Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets. J Mol Neurosci 71, 1725–1742 (2021). https://doi.org/10.1007/s12031-021-01841-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-021-01841-7